Trials / Completed
CompletedNCT02872207
Evaluation of the Stinging Potential in Human Eyes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to compare the human eye stinging potential of experimental formulas and an industry standard shampoo mixture. The study was conducted under the supervision of a Board Certified Ophthalmologist.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BAY 987516 (Y65-122) | 5 µL in one eye |
| DRUG | BAY 987516 (Y65-118) | 5 µL in one eye |
| DRUG | Control | 5 uL in other eye |
Timeline
- Start date
- 2015-02-21
- Primary completion
- 2015-02-22
- Completion
- 2015-02-22
- First posted
- 2016-08-19
- Last updated
- 2018-12-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02872207. Inclusion in this directory is not an endorsement.